- Home
- TNXP vs CBFV Comparison
TNXP vs CBFV Comparison
Compare TNXP & CBFV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TNXP | CBFV |
|---|---|---|
| Founded | 2007 | 1901 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 198.6M | 180.9M |
| IPO Year | 2008 | 2014 |
Fundamental Metrics
Financial Performance| Metric | TNXP | CBFV |
|---|---|---|
| Price | $12.74 | $35.82 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $38.00 |
| AVG Volume (30 Days) | ★ 382.0K | 2.0K |
| Earning Date | 05-11-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 3.05% |
| EPS Growth | ★ 91.75 | N/A |
| EPS | N/A | ★ 0.92 |
| Revenue | $13,107,000.00 | ★ $43,557,000.00 |
| Revenue This Year | $558.11 | $48.93 |
| Revenue Next Year | $38.29 | $7.97 |
| P/E Ratio | ★ N/A | $38.93 |
| Revenue Growth | ★ 29.85 | N/A |
| 52 Week Low | $11.60 | $27.11 |
| 52 Week High | $69.65 | $37.75 |
Technical Indicators
Market Signals| Indicator | TNXP | CBFV |
|---|---|---|
| Relative Strength Index (RSI) | 43.00 | 56.23 |
| Support Level | $11.90 | $34.01 |
| Resistance Level | $14.52 | $36.64 |
| Average True Range (ATR) | 0.76 | 0.33 |
| MACD | -0.05 | -0.02 |
| Stochastic Oscillator | 22.75 | 62.12 |
Price Performance
Historical ComparisonAbout TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.
About CBFV CB Financial Services Inc.
CB Financial Services Incis a bank holding company headquartered in Carmichaels, Pennsylvania. The company had one reportable segment, community banking services. The Bank also has a loan production office in Allegheny County, a loan production office and a corporate center in Washington County, and an operations center in Greene County, Pennsylvania. The Bank is a community-oriented institution offering residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a variety of deposit products for individuals and businesses in its market area.